This inventor holds 3 USPTO granted patents. Top assignees: Taiho Pharmaceutical Company Limited, Taiho Pharmaceutical. Active years: 1990-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tokushima, JP (1990)
- Saitama, JP (1999 - 2000)
Company Filing History:
Years Active: 1990-2000
Title: The Innovations of Yoshikazu Sugimoto
Introduction
Yoshikazu Sugimoto is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of oligonucleotides and anticancer agents. With a total of 3 patents to his name, Sugimoto's work has the potential to impact cancer treatment and molecular biology.
Latest Patents
Among his latest patents are "Double-stranded oligonucleotide and anticancer agent containing the same" and "Triplex Oligonucleotides targeted to p120." These innovations reflect his commitment to advancing medical science and improving therapeutic options for patients.
Career Highlights
Sugimoto has worked with Taiho Pharmaceutical Company Limited, where he contributed to various research projects. His experience in the pharmaceutical industry has provided him with a solid foundation for his inventive endeavors.
Collaborations
Throughout his career, Sugimoto has collaborated with esteemed colleagues such as Yuji Yamada and Ken-ichi Matsuo. These partnerships have likely enriched his research and led to fruitful innovations.
Conclusion
Yoshikazu Sugimoto's contributions to biotechnology and his innovative patents highlight his role as a significant figure in the field. His work continues to inspire advancements in cancer treatment and molecular research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile